Enacademic πŸŽ“Analogindex
50 subscribers
77.4K photos
2 videos
249K links
Download Telegram
Π’ΠΎΠ΅Π½Π½Ρ‹Π΅ Ρ‡ΠΈΠ½Ρ‹ ΠΈ Π·Π½Π°ΠΊΠΈ

ΠŸΠ΅Ρ€ΡΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π°Π½Π³ΠΈ воСннослуТащих французской Π°Ρ€ΠΌΠΈΠΈ дСлились Π½Π° Π³Π΅Π½Π΅Ρ€Π°Π»ΡŒΡΠΊΠΈΠ΅, офицСрскиС ΠΈ ΡƒΠ½Ρ‚Π΅Ρ€-офицСрскиС.via forma full 5 https://ift.tt/lZ0k7YD Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
ΠšΡƒΡ€ΡΠ°Π½Ρ‚ΡΠΊΠΈΠ΅ ΠΏΠΎΠ³ΠΎΠ½Ρ‹

ΠšΡƒΡ€ΡΠ°Π½Ρ‚ΡΠΊΠΈΠ΅ ΠΏΠΎΠ³ΠΎΠ½Ρ‹ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ ΠΎΡ‚Π»ΠΈΡ‡Π°ΡŽΡ‚ΡΡ ΠΎΡ‚ Ρ‚Π΅Ρ…, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ носят ΠΎΡ„ΠΈΡ†Π΅Ρ€Ρ‹, ΠΊΠ°ΠΊ внСшнС, Ρ‚Π°ΠΊ ΠΈ ΠΏΠΎ Π·Π½Π°Ρ‡Π΅Π½ΠΈΡŽ. ΠšΡƒΡ€ΡΠ°Π½Ρ‚ - это Π΄ΠΎΠ»ΠΆΠ½ΠΎΡΡ‚ΡŒ...via forma full 5 https://ift.tt/wnDvCze Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
*ΠΠ°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Π°Ρ*

Π€Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½Π°Ρ слуТба войск Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ Π³Π²Π°Ρ€Π΄ΠΈΠΈ Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ (Росгвардия) β€” Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½Ρ‹ΠΉ ΠΎΡ€Π³Π°Π½ ΠΈΡΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ власти Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ, спСцслуТба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3581058.html)
ΠΠ°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Π°Ρ

Π€Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½Π°Ρ слуТба войск Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ Π³Π²Π°Ρ€Π΄ΠΈΠΈ Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ (Росгвардия) β€” Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½Ρ‹ΠΉ ΠΎΡ€Π³Π°Π½ ΠΈΡΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ власти Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ, спСцслуТба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
*ΠšΠ°ΠΌΡƒΡ„Π»ΡΠΆΠΈ Π°Ρ€ΠΌΠΈΠΉ ΠΌΠΈΡ€Π°*

Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Π΅ камуфляТи Π“Π΅Ρ€ΠΌΠ°Π½ΠΈΠΈ Из всСх Π·Π°ΠΏΠ°Π΄Π½Ρ‹Ρ… стран ГСрмания ΠΈΠΌΠ΅Π΅Ρ‚ наибольший ΠΎΠΏΡ‹Ρ‚ создания собствСнных камуфляТных расцвСток. БобствСнно, ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ камуфляТ Ρƒ Π½Π΅ΠΌΡ†Π΅Π² появился Π΅Ρ‰Π΅ Π² ΠŸΠ΅Ρ€Π²ΡƒΡŽ ΠΌΠΈΡ€ΠΎΠ²ΡƒΡŽ.via forma full 5 https://ift.tt/vG0KueX Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.tumblr.com/post/737411780470505472)
ΠšΠ°ΠΌΡƒΡ„Π»ΡΠΆΠΈ Π°Ρ€ΠΌΠΈΠΉ ΠΌΠΈΡ€Π°

Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Π΅ камуфляТи Π“Π΅Ρ€ΠΌΠ°Π½ΠΈΠΈ Из всСх Π·Π°ΠΏΠ°Π΄Π½Ρ‹Ρ… стран ГСрмания ΠΈΠΌΠ΅Π΅Ρ‚ наибольший ΠΎΠΏΡ‹Ρ‚ создания собствСнных камуфляТных расцвСток. БобствСнно, ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ камуфляТ Ρƒ Π½Π΅ΠΌΡ†Π΅Π² появился Π΅Ρ‰Π΅ Π² ΠŸΠ΅Ρ€Π²ΡƒΡŽ ΠΌΠΈΡ€ΠΎΠ²ΡƒΡŽ.via forma full 5 https://ift.tt/vG0KueX Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
*ΠŸΠΎΡ‡Π΅ΠΌΡƒ Ρ„ΠΈΠ»ΡŒΠΌΡ‹ ΠΎ ΠŸΠ΅Ρ€ΡΠΈ ДТСксонС Ρ€Π°Π·ΠΎΡ‡Π°Ρ€ΠΎΠ²Π°Π»ΠΈ ΠΈ ΠΊΠ°ΠΊ сСриал ΠΌΠΎΠΆΠ΅Ρ‚ это ΠΈΡΠΏΡ€Π°Π²ΠΈΡ‚ΡŒ*

А Π²ΠΎΡ‚ Ρƒ ΠΊΠ½ΠΈΠ³ большая Ρ„Π°Π½-Π±Π°Π·Π°!
[Read more...](https://burninghut.ru/persi-dzhekson/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=persi-dzhekson)
*Nike slumps after cutting full-year sales forecast on sportswear weakness*

Updated at 7:36 AM EST Nike (NKE) - Get Free Report shares fell sharply in early Friday trading after the sportswear giant issued a muted full-year revenue outlook and cost-cutting plan that offset a solid fiscal-second-quarter earnings report. Nike said for the three months ended in November came in at $1.03 a share, up 21% from the year-earlier period and firmly ahead of the Wall Street consensus forecast of an 85-cent profit. Group revenue, however, rose only 1% from last year earlier to $13.4 billion, just shy of analysts' estimates of a $13.43 billion tally. China revenue was also light of forecasts, rising 8% to $1.86 billion, while North America revenue was down 3.5% to $5.63 billion. Gross margin improved modestly, widening 40 basis points (0.4 percentage point) from the prior quarter and 1.7 percentage points from a year earlier to 44.6%, thanks to fewer markdowns and cheaper shipping costs.Nike seeks to cut $2 billion of costs Looking into the second half of its financial year, Nike sees revenue growing by a similar amount compared with its autumn forecast of 'mid-single-digit-percent' gains, thanks in part to weakness in China and "increased macro headwinds." As a result, Nike said, it was looking to cut another $2 billion in costs over the next three years, with a focus on supply-chain efficiency, more automation and mid-management job cuts. "Last quarter, as I provided guidance, I highlighted a number of risks in our operating environment, including the effects of a stronger U.S. dollar on foreign-currency translation, consumer demand over the holiday season, and our second-half wholesale order books," chief financial officer Matt Friend told investors on a conference call late Thursday. "Looking forward, the impact of these risks is becoming clearer, and as a result, we are adjusting our full-year financial outlook," he added. "As we move forward, our focus is building a faster, more efficient Nike and embracing the opportunities in front of us to accelerate sustainable and more profitable growth." Nike shares were marked 12.8% lower in premarket trading to indicate an opening bell price of $106.90 each. Foot Locker (FL) - Get Free Report, which relies heavily on Nike for its retail sales, was marked 7.12% lower at $30 each while German sportswear rival Adidas (ADDYY) - Get Free Report slumped 6% in Frankfurt. "Nike posted slightly softer than expected top-line results amid a difficult macro, with gross margin expansion and timing shifts in expenses led to a solid earnings beat," said KeyBanc Capital Markets analyst Ashley Owens. She carries a sector weight rating on the stock. "We are encouraged by momentum in (Asia and Latin America) but a strong second-half recovery in China looks to be out of focus due to increasing macro headwinds, and helped drive a downward revision to guidance, and we think reduced guidance implies ongoing uncertainty in the near term," she added.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/stocks/nike-slumps-after-cutting-full-year-sales-forecast-on-sportswear-weakness)
*This Game-Changing Sleep Mask Works Better Than Blackout Curtains and Is My Secret to a Full Night’s Sleep*

I wasn't an eye mask person before, but I am now! READ MORE...
[Read more...](https://www.apartmenttherapy.com/manta-sleep-mask-review-ll-37357908?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
Nike slumps after cutting full-year sales forecast on sportswear weakness

Updated at 7:36 AM EST Nike (NKE) - Get Free Report shares fell sharply in early Friday trading after the sportswear giant issued a muted full-year revenue outlook and cost-cutting plan that offset a solid fiscal-second-quarter earnings report. Nike said for the three months ended in November came in at $1.03 a share, up 21% from the year-earlier period and firmly ahead of the Wall Street consensus forecast of an 85-cent profit. Group revenue, however, rose only 1% from last year earlier to $13.4 billion, just shy of analysts' estimates of a $13.43 billion tally. China revenue was also light of forecasts, rising 8% to $1.86 billion, while North America revenue was down 3.5% to $5.63 billion. Gross margin improved modestly, widening 40 basis points (0.4 percentage point) from the prior quarter and 1.7 percentage points from a year earlier to 44.6%, thanks to fewer markdowns and cheaper shipping costs.Nike seeks to cut $2 billion of costs Looking into the second half of its financial year, Nike sees revenue growing by a similar amount compared with its autumn forecast of 'mid-single-digit-percent' gains, thanks in part to weakness in China and "increased macro headwinds." As a result, Nike said, it was looking to cut another $2 billion in costs over the next three years, with a focus on supply-chain efficiency, more automation and mid-management job cuts. "Last quarter, as I provided guidance, I highlighted a number of risks in our operating environment, including the effects of a stronger U.S. dollar on foreign-currency translation, consumer demand over the holiday season, and our second-half wholesale order books," chief financial officer Matt Friend told investors on a conference call late Thursday. "Looking forward, the impact of these risks is becoming clearer, and as a result, we are adjusting our full-year financial outlook," he added. "As we move forward, our focus is building a faster, more efficient Nike and embracing the opportunities in front of us to accelerate sustainable and more profitable growth." Nike shares were marked 12.8% lower in premarket trading to indicate an opening bell price of $106.90 each. Foot Locker (FL) - Get Free Report, which relies heavily on Nike for its retail sales, was marked 7.12% lower at $30 each while German sportswear rival Adidas (ADDYY) - Get Free Report slumped 6% in Frankfurt. "Nike posted slightly softer than expected top-line results amid a difficult macro, with gross margin expansion and timing shifts in expenses led to a solid earnings beat," said KeyBanc Capital Markets analyst Ashley Owens. She carries a sector weight rating on the stock. "We are encouraged by momentum in (Asia and Latin America) but a strong second-half recovery in China looks to be out of focus due to increasing macro headwinds, and helped drive a downward revision to guidance, and we think reduced guidance implies ongoing uncertainty in the near term," she added.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
*Karuna Therapeutics soars after $14 billion takeover by Bristol Myers*

Karuna Therapeutics (KRTX) - Get Free Report shares soared Friday after the neurological-drug specialists agreed to a $14 billion takeover by pharma giant Bristol Myers Squibb (BMY) - Get Free Report. Bristol Myers said it would pay $330 a share cash for the Boston drugmaker, a 53% premium to its Thursday closing price, a deal that values the group at around $14 billion. Karuna focuses on treatments for patients suffering psychiatric and neurological conditions. Last month the Food and Drug Administration accepted its new-drug application for KarXT, a drug designed to treat schizophrenia. β€œSchizophrenia and Alzheimer’s disease psychosis affect millions of people worldwide, with limited to no treatment options," said Karuna's chief medical officer, Samit Hirawat. "KarXT’s novel mechanism has resulted in a transformational profile in schizophrenia, with compelling efficacy and a differentiated safety profile.” β€œKarXT also has the potential to deliver meaningful benefits to patients as an adjunctive treatment for patients with schizophrenia and as a first treatment for Alzheimer’s disease psychosis,” he added. Karuna Therapeutics shares were marked 47.5% higher in premarket trading immediately following news of the takeover to indicate an opening bell price of $317.50 Bristol Myers shares, meanwhile, slipped 1.6% to $59.45 each.Bristol Myers: Second major deal of '23 The deal marks the second major acquisition for Bristol Myers this year, following its $5.8 billion purchase of San Diego cancer-drug specialists Mirati Therapeutics (MRTX) - Get Free Report in October. β€œThere are tremendous opportunities in neuroscience, and Karuna strengthens our position and accelerates the expansion and diversification of our portfolio in the space," said Bristol Myers CEO Chris Boerner. "We expect KarXT to enhance our growth through the late 2020s and into the next decade." β€œThis transaction fits squarely within our business development priorities of pursuing assets that are strategically aligned, scientifically sound, financially attractive, and have the potential to address areas of significant unmet medical need," he added. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/karuna-therapeutics-soars-after-14-billion-takeover-by-bristol-myers)
Karuna Therapeutics soars after $14 billion takeover by Bristol Myers

Karuna Therapeutics (KRTX) - Get Free Report shares soared Friday after the neurological-drug specialists agreed to a $14 billion takeover by pharma giant Bristol Myers Squibb (BMY) - Get Free Report. Bristol Myers said it would pay $330 a share cash for the Boston drugmaker, a 53% premium to its Thursday closing price, a deal that values the group at around $14 billion. Karuna focuses on treatments for patients suffering psychiatric and neurological conditions. Last month the Food and Drug Administration accepted its new-drug application for KarXT, a drug designed to treat schizophrenia. β€œSchizophrenia and Alzheimer’s disease psychosis affect millions of people worldwide, with limited to no treatment options," said Karuna's chief medical officer, Samit Hirawat. "KarXT’s novel mechanism has resulted in a transformational profile in schizophrenia, with compelling efficacy and a differentiated safety profile.” β€œKarXT also has the potential to deliver meaningful benefits to patients as an adjunctive treatment for patients with schizophrenia and as a first treatment for Alzheimer’s disease psychosis,” he added. Karuna Therapeutics shares were marked 47.5% higher in premarket trading immediately following news of the takeover to indicate an opening bell price of $317.50 Bristol Myers shares, meanwhile, slipped 1.6% to $59.45 each.Bristol Myers: Second major deal of '23 The deal marks the second major acquisition for Bristol Myers this year, following its $5.8 billion purchase of San Diego cancer-drug specialists Mirati Therapeutics (MRTX) - Get Free Report in October. β€œThere are tremendous opportunities in neuroscience, and Karuna strengthens our position and accelerates the expansion and diversification of our portfolio in the space," said Bristol Myers CEO Chris Boerner. "We expect KarXT to enhance our growth through the late 2020s and into the next decade." β€œThis transaction fits squarely within our business development priorities of pursuing assets that are strategically aligned, scientifically sound, financially attractive, and have the potential to address areas of significant unmet medical need," he added. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
*ЀинансовыС экспСрты выяснили, сколько Π·Π°Ρ€Π°Π±Π°Ρ‚Ρ‹Π²Π°Π»ΠΈ Ρ€ΠΎΠ΄ΠΈΡ‚Π΅Π»ΠΈ КСвина ΠΈΠ· Ρ„ΠΈΠ»ΡŒΠΌΠ° «Один Π΄ΠΎΠΌΠ°Β»*

Π’Π°ΠΊΠΆΠ΅ Π΅ΡΡ‚ΡŒ ΠΏΡ€Π΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅, ΠΊΠ΅ΠΌ ΠΎΠ½ΠΈ Ρ€Π°Π±ΠΎΡ‚Π°Π»ΠΈ.
[Read more...](https://lifehacker.ru/skolko-zarabatyvali-makkalistery/)
*ΠŸΠΎΠ΄ΠΎΡˆΠ²Ρ‹ кроссовок*

ЀитнСс, Π±Π΅Π³, ΠΊΠΎΠΌΠ°Π½Π΄Π½Ρ‹Π΅ Π²ΠΈΠ΄Ρ‹ спорта, ΠΏΠ°Ρ€ΠΊΡƒΡ€, занятия Π² Π·Π°Π»Π΅ ΠΈ Π½Π° ΡƒΠ»ΠΈΡ†Π΅ Ρ‚Ρ€Π΅Π±ΡƒΡŽΡ‚ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ Ρ‚ΠΈΠΏΠ° ΠΏΠΎΠ΄ΠΎΡˆΠ²Ρ‹ спортивной ΠΎΠ±ΡƒΠ²ΠΈ. НапримСр, Π±Π°ΡΠΊΠ΅Ρ‚Π±ΠΎΠ»ΡŒΠ½Ρ‹Π΅ кроссовки для ΡƒΠ»ΠΈΡ†Ρ‹ ΠΈΠΌΠ΅ΡŽΡ‚ ΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€ Π² Π²ΠΈΠ΄Π΅ Π΅Π»ΠΎΡ‡ΠΊΠΈ , ΠΈΠ½Π°Ρ‡Π΅ ΠΈΠ³Ρ€ΠΎΠΊ Π±ΡƒΠ΄Π΅Ρ‚ ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3580841.html)
*ΠšΠ°ΠΌΡƒΡ„Π»ΡΠΆΠΈ Π°Ρ€ΠΌΠΈΠΉ ΠΌΠΈΡ€Π°*

Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Π΅ камуфляТи Π“Π΅Ρ€ΠΌΠ°Π½ΠΈΠΈ Из всСх Π·Π°ΠΏΠ°Π΄Π½Ρ‹Ρ… стран ГСрмания ΠΈΠΌΠ΅Π΅Ρ‚ наибольший ΠΎΠΏΡ‹Ρ‚ создания собствСнных камуфляТных расцвСток. БобствСнно, ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ камуфляТ Ρƒ Π½Π΅ΠΌΡ†Π΅Π² появился Π΅Ρ‰Π΅ Π² ΠŸΠ΅Ρ€Π²ΡƒΡŽ ΠΌΠΈΡ€ΠΎΠ²ΡƒΡŽ.via forma full 5 https://ift.tt/vG0KueX Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3587026.html)
ΠŸΠΎΠ΄ΠΎΡˆΠ²Ρ‹ кроссовок

ЀитнСс, Π±Π΅Π³, ΠΊΠΎΠΌΠ°Π½Π΄Π½Ρ‹Π΅ Π²ΠΈΠ΄Ρ‹ спорта, ΠΏΠ°Ρ€ΠΊΡƒΡ€, занятия Π² Π·Π°Π»Π΅ ΠΈ Π½Π° ΡƒΠ»ΠΈΡ†Π΅ Ρ‚Ρ€Π΅Π±ΡƒΡŽΡ‚ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ Ρ‚ΠΈΠΏΠ° ΠΏΠΎΠ΄ΠΎΡˆΠ²Ρ‹ спортивной ΠΎΠ±ΡƒΠ²ΠΈ. НапримСр, Π±Π°ΡΠΊΠ΅Ρ‚Π±ΠΎΠ»ΡŒΠ½Ρ‹Π΅ кроссовки для ΡƒΠ»ΠΈΡ†Ρ‹ ΠΈΠΌΠ΅ΡŽΡ‚ ΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€ Π² Π²ΠΈΠ΄Π΅ Π΅Π»ΠΎΡ‡ΠΊΠΈ , ΠΈΠ½Π°Ρ‡Π΅ ΠΈΠ³Ρ€ΠΎΠΊ Π±ΡƒΠ΄Π΅Ρ‚ ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
ΠšΠ°ΠΌΡƒΡ„Π»ΡΠΆΠΈ Π°Ρ€ΠΌΠΈΠΉ ΠΌΠΈΡ€Π°

Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Π΅ камуфляТи Π“Π΅Ρ€ΠΌΠ°Π½ΠΈΠΈ Из всСх Π·Π°ΠΏΠ°Π΄Π½Ρ‹Ρ… стран ГСрмания ΠΈΠΌΠ΅Π΅Ρ‚ наибольший ΠΎΠΏΡ‹Ρ‚ создания собствСнных камуфляТных расцвСток. БобствСнно, ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ камуфляТ Ρƒ Π½Π΅ΠΌΡ†Π΅Π² появился Π΅Ρ‰Π΅ Π² ΠŸΠ΅Ρ€Π²ΡƒΡŽ ΠΌΠΈΡ€ΠΎΠ²ΡƒΡŽ.via forma full 5 https://ift.tt/vG0KueX Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...